Achmea Investment Management B.V. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 94,604 shares of the healthcare conglomerate's stock after acquiring an additional 18,734 shares during the quarter. UnitedHealth Group accounts for 0.7% of Achmea Investment Management B.V.'s portfolio, making the stock its 28th biggest holding. Achmea Investment Management B.V.'s holdings in UnitedHealth Group were worth $49,549,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Price Performance
UNH opened at $302.43 on Friday. The firm has a market capitalization of $274.35 billion, a PE ratio of 12.66, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The business's 50-day moving average is $339.15 and its two-hundred day moving average is $456.28. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the business earned $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.
Insider Activity
In related news, CFO John F. Rex purchased 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.
Analysts Set New Price Targets
UNH has been the topic of a number of research analyst reports. Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday, June 20th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, KeyCorp cut their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $415.57.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.